Caidya®

CMC Considerations in Development of Cell Therapies

CMC Considerations for Cell Therapies

Learn the essential CMC considerations for cell therapies, from sourcing and manufacturing controls to regulatory strategies and release testing best practices.

Download the White Paper

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

News

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...
Read more

News

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...
Read more

News

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Read more
Skip to toolbar